---
title: "14:27 ETSHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285420865.md"
description: "Class Action Attorney Juan Monteverde with Monteverde & Associates PC is investigating mergers involving Helix Energy Solutions Group (HLX), Organon & Co. (OGN), XOMA Royalty Corporation (XOMA), and RE/MAX Holdings, Inc. (RMAX). Helix shareholders will own 45% of the combined company post-merger, while Organon shareholders will receive $14.00 per share, XOMA shareholders $39.00 per share, and RE/MAX shareholders will receive either shares or $13.80 in cash. The firm has a successful track record in recovering funds for shareholders."
datetime: "2026-05-06T18:27:21.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285420865.md)
  - [en](https://longbridge.com/en/news/285420865.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285420865.md)
---

# 14:27 ETSHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX

, /PRNewswire/ -- **Class Action Attorney** Juan Monteverde **with** Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50 Firm** in the 2025 ISS Securities Class Action Services Report. We are headquartered at the **Empire State Building** in New York City and are investigating

-   **Helix Energy Solutions Group, Inc. (NYSE: HLX)** related to its merger with Hornbeck Offshore Services, Inc. Upon completion of the proposed transaction, Helix shareholders will own approximately 45% of the combined company on a fully diluted basis.

**Click here for more information https://monteverdelaw.com/case/helix-energy-solutions-group-inc/****.** **It is free and there is no cost or obligation to you.**

-   **Organon & Co. (NYSE: OGN)** related to its sale to Sun Pharmaceuticals Industries Limited. Under the terms of the proposed transaction, Organon shareholders will receive $14.00 per share in cash.

**Click here for more information** **https://monteverdelaw.com/case/organon-co/****.** **It is free and there is no cost or obligation to you.**

-   **XOMA Royalty Corporation (NASDAQ: XOMA)** related to its sale to Ligand Pharmaceuticals Incorporated. Under the terms of the proposed transaction, XOMA shareholders will receive $39.00 per share in cash.

**Click here for more information https://monteverdelaw.com/case/xoma-royalty-corporation/****.** **It is free and there is no cost or obligation to you.**

-   **RE/MAX Holdings, Inc. (NYSE: RMAX)** related to its sale to The Real Brokerage Inc. Under the terms of the proposed transaction, RE/MAX shareholders are expected to receive either 5.152 shares of the combined company or $13.80 in cash per share.

**Click here for more info** **https://monteverdelaw.com/case/re-max-holdings-inc/****.** **It is free and there is no cost or obligation to you.**

**NOT ALL LAW FIRMS ARE THE SAME.** Before you hire a law firm, you should talk to a lawyer and ask:

1.  Do you file class actions and go to Court?
2.  When was the last time you recovered money for shareholders?
3.  What cases did you recover money in and how much?

**About Monteverde & Associates PC**

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.

**No company, director or officer is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341.

Contact:  
Juan Monteverde, Esq.  
MONTEVERDE & ASSOCIATES PC  
**The Empire State Building  
**350 Fifth Ave. Suite 4740  
New York, NY 10118  
United States of America  
\[email protected\]  
Tel: (212) 971-1341

Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE Monteverde & Associates PC

### Related Stocks

- [HLX.US](https://longbridge.com/en/quote/HLX.US.md)
- [OGN.US](https://longbridge.com/en/quote/OGN.US.md)
- [XOMA.US](https://longbridge.com/en/quote/XOMA.US.md)
- [RMAX.US](https://longbridge.com/en/quote/RMAX.US.md)
- [LGND.US](https://longbridge.com/en/quote/LGND.US.md)
- [REAX.US](https://longbridge.com/en/quote/REAX.US.md)
- [XOMAP.US](https://longbridge.com/en/quote/XOMAP.US.md)
- [XOMAO.US](https://longbridge.com/en/quote/XOMAO.US.md)

## Related News & Research

- [District Announces Promising Water Treatment Results from Collaboration with Xoma AB | DMXCF Stock News](https://longbridge.com/en/news/286861678.md)
- [17:25 ETAre XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders?](https://longbridge.com/en/news/286471428.md)
- [Organon to Present New Research on Access and Value at ISPOR 2026 | OGN Stock News](https://longbridge.com/en/news/286556635.md)
- [Ligand Pharmaceuticals Amends XOMA Royalty Merger Agreement to Add Holding Company](https://longbridge.com/en/news/286776618.md)
- [RE/MAX HOLDINGS, INC. REPORTS FIRST QUARTER 2026 RESULTS | RMAX Stock News](https://longbridge.com/en/news/285709542.md)